Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
7
78%
Ph phase_4
1
11%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(3)
Other(4)

Detailed Status

unknown4
Completed3
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (12.5%)
N/A7 (87.5%)

Trials by Status

unknown444%
completed333%
not_yet_recruiting111%
recruiting111%

Recent Activity

1 active trials
Showing 5 of 9
recruiting

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

NCT00898313
completednot_applicable

Validation of Respiratory Epithelial Functional Assessment to Predict Clinical Efficacy of Orkambi®.

NCT03894657
not_yet_recruitingnot_applicable

Implementation of a Joint Pulmonologist and ENT Consultation in the Care Pathway of Patients Suffering From Asthma and Chronic Rhinosinusitis With Nasal Polyposis: Effectiveness Compared With Consultations by Specialty (CON-PO Study).

NCT07134686
completednot_applicable

Effects of Prenatal Tobacco Smoke Exposure on Lung Function and Respiratory Epithelium Functionality in Newborns

NCT03047967
unknownnot_applicable

Nasal Brushing for the Diagnosis and Understanding of Telomeropathies

NCT05508321
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT00898313

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

Recruiting
NCT03894657Not Applicable

Validation of Respiratory Epithelial Functional Assessment to Predict Clinical Efficacy of Orkambi®.

Completed
NCT07134686Not Applicable

Implementation of a Joint Pulmonologist and ENT Consultation in the Care Pathway of Patients Suffering From Asthma and Chronic Rhinosinusitis With Nasal Polyposis: Effectiveness Compared With Consultations by Specialty (CON-PO Study).

Not Yet Recruiting
NCT03047967Not Applicable

Effects of Prenatal Tobacco Smoke Exposure on Lung Function and Respiratory Epithelium Functionality in Newborns

Completed
NCT05508321Not Applicable

Nasal Brushing for the Diagnosis and Understanding of Telomeropathies

Unknown
NCT04590261Not Applicable

Myeloid Cells in Patients With Covid-19 Pneumonia

Unknown
NCT02951559Phase 4

SOLFAMU Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human Encephalopathies

Unknown
NCT02433132Not Applicable

Cystic Fibrosis Diagnosis by Analyzing Nasal Brushing

Unknown
NCT02351830Not Applicable

Clinical Validation of Birch Pollen in the EEU

Completed

All 9 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
9